Christopher Sweeney, James A. Proudfoot, Simranjeet Kaur, Darby Thompson, Martin R. Stockler, Monica Guilhaus, Hayley Thomas, Vinod Subhash, Samantha Richelle Oakes, Emily Grist, Anis Hamid, Sonia Yip, Arun Azad, Lisa Horvath, James G. Kench, Elai Davicioni, Gerhardt Attard, Ian D. Davis. "Assessment of the ability of Decipher Prostate Genomic Classifier (DGC) >0.85 to identify patients who benefit from adding docetaxel (DOC) to androgen deprivation therapy (ADT) plus enzalutamide (ENZ): Level 1B evidence from the ENZAMET study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5001